🔓 Unlock the full profile of Amirali Talasaz (Guardant Health), including verified contact details, financial insights, and professional associations.
See Amirali Talasaz Full ProfileBelow are the ✅ Verified Contact Details to help you connect directly:
Email: ami*****@gua******.com
Mobile: 98696*****
Estimated Net Worth 💰 : ₹0 – ₹500+ Cr (approx. $0 – $60M)
Key Insights You Should Know About This Individual
- Amirali Talasaz is a Co-founder and Co-Chief Executive Officer of Guardant Health, an innovative company focused on blood-based cancer tests to enhance patient care and treatment options.
- Guardant Health was established in 2012 and quickly gained recognition for its advanced liquid biopsy technology, which provides vital genomic information to inform cancer treatment decisions.
- During Amirali Talasaz's tenure, the company went public under the symbol 'GH' on the NASDAQ, reflecting its growth and the significant demand for its services, with a market capitalization of approximately $5.2 billion.
- Prior to this role, Amirali Talasaz served as Co-founder, President, and Chairman of Guardant Health, contributing to the initial shaping and strategic direction of the organization.
- Before joining Guardant Health, Amirali Talasaz held various key positions at Illumina, including Senior Director of Scientific Research, where contributions significantly advanced the field of genomic research.
- In 2008, Amirali Talasaz co-founded Auriphex Biosciences, showcasing a commitment to fostering innovation within the biotechnology sector.
- As Engineering Research Associate and Technology Lead at the Stanford Genome Technology Center, valuable expertise was developed that underpins many of the technologies employed within Guardant Health today.
- The leadership and vision of Amirali Talasaz have played a crucial role in establishing Guardant Health as a leader in precision oncology, enhancing the accessibility and effectiveness of cancer diagnostics.